← All organizations

Akela Pharma, Inc.

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 1, 2008

Defunct as of Dec 1, 2018

Timeline

1970s

Jun 1, 1979
Akela Pharma, Inc.— Founded

2000s

Jun 1, 2009
Nventa Biopharmaceuticals Corporation— Acquired

2010s

Dec 1, 2018
Akela Pharma, Inc.— Defunct

Drugs by trial phase (4 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

fentanyl

Phase 2 (0 own, 1 via acquisition)

sgn-00101

Phase 1 (0 own, 2 via acquisition)

Indications

Studied for

Cancer Pain

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Nventa Biopharmaceuticals Corporation

Recent trials (1)

NCT00822614Lead sponsorPhase 3Dec 1, 2008

Details

Founded: Austin, TX, US Jun 1, 1979
Last known activity: Dec 1, 2008

Notes

CRO